Post on 28-Jun-2020
transcript
LURIE CANCER CENTER M
ultidisciplinary Head & Neck Symposium
Novem
ber 10-11, 2018
Northw
estern Mem
orial Hospital Feinberg Pavilion 3rd Floor Conference Center 251 E. Huron St., Chicago
CON
FERENCE CH
AIR
Sandeep Samant, M
DChief, H
ead & N
eck Surgery N
orthwestern M
edicine
VISIT OU
R WEBSITE:
cancer.northwestern.edu/headneck
QU
ESTION
S:
erin.donoghue@northw
estern.edu
Agenda & Program Inform
ation
The Lurie Cancer Center Multidisciplinary Head & Neck Symposium is a one and one-half day interactive program on the diagnosis, treatment and rehabilitation of head and neck cancer patients. The symposium brings together medical oncologists, radiation oncologists, otolaryngologists, head and neck surgeons, dentists, nurses and allied health professionals to discuss and debate the latest advances in multidisciplinary therapies, clinical research and supportive care methodology. The agenda features internationally-recognized experts who will engage attendees in dialogue to improve multi-specialty collaboration in the treatment and care of head and neck cancer patients.
cancer.northwestern.edu/headneck
676 N St. Clair, Suite 1200Chicago, IL 60611
Register by August 31 for early bird discount; prices increase September 1.
LURIE CANCER CENTER Multidisciplinary Head & Neck SymposiumNovember 10-11, 2018
LEARNING OBJECTIVES 1. Apply a multidisciplinary approach to the treatment of head and neck cancer.2. Assess state-of-the art therapeutic options for the treatment of head and neck cancer including:
i. Minimally invasive surgical treatment including robotic surgery, image-guided skull base surgery, and sentinel lymph node mapping.
ii. Novel radiation delivery methods including proton beam therapy and Image-Guided Radiation Therapy (IGRT). iii. Incorporation of immunotherapy for treatment of advanced head and neck cancer.
3. Discuss future directions to the treatment of head and neck cancer based on the latest basic science and clinical developments including:
i. The diagnosis and treatment of human papillomavirus (HPV) positive oropharyngeal. ii. The latest developments in the molecular biology of head and neck cancer and its impact on management.iii. The role of biomarkers in the contemporary management of head and neck cancer. iv. Strategies for recognition and treatment of adverse effects of immunotherapy.
4. Discuss new staging guidelines (8th edition AJCC) for head and neck cancer.5. Apply current treatment guidelines to patients with head and neck cancer. 6. Integrate quality measures for the care of head and neck cancer into their own clinical practice.
7:45 a.m. - Opening RemarksSandeep Samant, MD
8:00 a.m. - Oropharynx Cancer IModerator: Robert Haddad, MDRisk Stratification in Oropharynx Cancer: Sue Yom, MD, PhD Radiation Strategies for De-Intensification: Paul Harari, MDChemotherapeutic Considerations: Dimitri Colevas, MDCase Discussion: A. Dimitri Colevas, MD; Paul Harari, MD; Randal Weber, MD; Sue Yom, MD, PhD
9:30 a.m. - Larynx CancerModerator: Gregory Wolf, MDOrgan Preservation Surgery for Larynx Cancer: Bruce Haughey, MDNonsurgical Organ Preservation: Robert Haddad, MDCase Discussion: Robert Haddad, MD; Bruce Haughey, MD; Bharat Mittal, MD
10:30 a.m. - Break10:45 a.m. - Oropharynx Cancer II
Moderator: Sandeep Samant, MDRisk Stratification after Surgery for Oropharynx Cancer, 8th Edition Staging: Bruce Haughey, MDInnovations in Surgical Technique and Technology: Chris Holsinger, MDAdjuvant Therapy in Oropharynx Cancer: Harry Quon, MDCase Discussion: A. Dimitri Colevas, MD; Bruce Haughey, MD; Chris Holsinger, MD; Harry Quon, MD
12:15 p.m. - Lunch1:15 p.m. - Oral Cavity
Moderator: Kerstin Stenson, MD Sentinel Node Biopsy for Early Oral Cancer: Sandeep Samant, MDReconstruction for Advanced Oral Cancer: Urjeet Patel, MDProsthetic Rehabilitation for Mandibular Defects: Mark Hutten, DDSAdjuvant Therapy for Oral Cancers: Timothy Kruser, MDCase Discussion: Mark Hutten, DDS; Timothy Kruser, MD; Urjeet Patel, MD; Sandeep Samant, MD
2:15 p.m. - ThyroidModerator: Ashok Shaha, MDMolecular Diagnosis of Thyroid Nodules: Whitney Liddy, MDRisk Stratification After Surgery and Indications of Radioactive Iodine Therapy: Peter Kopp, MDDrug Therapy for Thyroid Cancer: Maria Matsangou, MDIndications for EBRT in Thyroid Cancer: Sue Yom, MD, PhDCase Discussion: Chris Holsinger, MD; Peter Kopp, MD; Whitney Liddy, MD; Maria Matsangou, MD; Sue Yom, MD, PhD
3:45 p.m. - Break4:00 p.m. - Cutaneous Malignancies in Head and Neck Cancer
Moderator: Randal Weber, MDManagement of Lymphatic Metastasis in Head Neck Melanoma: Jeffrey Wayne, MDWhat’s New in the World of Cutaneous Head and Neck Malignancies: Sunandana Chandra, MD, MSHow Best to Utilize Mohs Surgery in Cutaneous Head Neck Cancer: Simon Yoo, MDNMSC at the Skull Base: Radiation Therapy Versus Combined Therapy: Sue Yom, MD, PhDCase Discussion: Sunandana Chandra, MD, MS; Jeffrey Sosman, MD; Jeffrey Wayne, MD; Sue Yom, MD, PhD; Simon Yoo, MD
5:45 p.m. - Adjourn
8:00 a.m. - Immunotherapy in Head and Neck CancerModerator: Jeffrey Sosman, MDAdvances in Immunotherapy for Cancer: Jeffrey Sosman, MDImmunotherapy for Recurrent/Metastatic Head and Neck Cancer: Tanguy Seiwert, MDCombining Immunotherapy with Radiotherapy: Zachary Morris, MD, PhDManagement of Adverse Effects with Immunotherapy: Doug Johnson, MDQuestion & Answer
9:30 a.m. - Unknown Primary CancerModerator: Urjeet Patel, MDModern Approaches for Identification of Unknown Primary: Chris Holsinger, MDAvoiding Pitfalls in Pathologic Diagnosis: Borislav Alexiev, MDImaging for Unknown Primary Cancer: Achilles Karagianis, DOWe identified the Primary, Now What? Harry Quon, MDCase Discussion: Borislav Alexiev, MD; Chris Holsinger, MD; Achilles Karagianis, DO; Harry Quon, MD
10:45 a.m. - Boxed Lunch Break 11:00 a.m. - Head and Neck Oncology: Where Are We Now and Where Are We Going? Coverage from the 2018 ASCO Annual Meeting
Mark Agulnik; MD, A. Dimitri Colevas, MD; Tanguy Seiwert, MD; Matthew Witek, MD
11:45 a.m. - Tumor Board: Paranasal Sinus, Nasopharynx, SalivaryModerator: Sandeep Samant, MDMichelle Gentile, MD; Harry Quon, MD, PhD; Kerstin Stenson, MD; Victoria Villaflor, MD; Randal Weber, MD
1:15 p.m. - Adjourn
Mark Agulnik, MDLurie Cancer Center
Borislav Alexiev, MDNorthwestern Medicine
Sunandana Chandra, MD, MSLurie Cancer Center
A. Dimitrios Colevas, MDStanford Cancer Center
Michelle Gentile, MDLurie Cancer Center
Robert Haddad, MDDana-Farber Cancer Institute
Paul Harari, MDUniversity of Wisconsin
Bruce Haughey, MDFlorida Hospital Medical Group
Chris Holsinger, MDStanford Cancer Center
Mark Hutten, DDSNorthwestern Medicine
Douglas Johnson, MDVanderbilt-Ingram Cancer Center
Achilles Karagianis, DONorthwestern Medicine
Peter Kopp, MDLausanne University Medical School
Timothy Kruser, MDLurie Cancer Center
Whitney Liddy , MDNorthwestern Medicine
Maria Matsangou, MBChBLurie Cancer Center
Bharat Mittal, MDLurie Cancer Center
Zachary Morris MD, PhDUniversity of Wisconsin
Urjeet Patel, MDNorthwestern Medicine
Harry Quon, MDSidney Kimmel Comprehensive Cancer Center
Sandeep Samant, MDNorthwestern Medicine
Tanguy Seiwert, MDThe University of Chicago Medicine
Ashok Shaha, MDMemorial Sloan Kettering Cancer Center
Jeffrey Sosman, MDLurie Cancer Center
Kerstin Stenson, MDRush University Medical Center
Victoria Villaflor, MDLurie Cancer Center
Jeffrey Wayne, MDLurie Cancer Center
Randal Weber, MDUniversity of Texas MD Anderson Cancer Center
Matthew Witek, MDUniversity of Wisconsin
Gregory Wolf, MDUniversity of Michigan Rogel Cancer Center
Sue Yom, MD, PhDUCSF Helen Diller Family Comprehensive Cancer Center
Simon Yoo, MDLurie Cancer Center
FACULTY
cancer.northwestern.edu/headneckTARGET AUDIENCEThe target audience for this activity includes Medical Oncologists, Radiation Oncologists, Surgical Oncologists, Fellows in training, Oncology Nurses, Oral Surgeons, Dentists, Speech Pathologists and Allied Health Professionals treating or interested in treating those with head and neck cancer.
ACCREDITATION STATEMENTThe Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATIONThe Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other CreditsThe American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits(s)™ from organizations accredited by the ACCME.
OTHER CREDITSThe American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits(s)™ from organizations accredited by the ACCME.
SATURDAY, NOVEMBER 10 SUNDAY, NOVEMBER 11
This symposium is made possible, in part, by the generous endowed gift of Harry Staffileno, Jr., DDS, MS to support oncology-related oral health at Northwestern Medicine.